ATAI Life Sciences N.V. financial data

Symbol
ATAI on Nasdaq
Location
Wallstrasse 16, Berlin, Germany
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 449 % -39.2%
Debt-to-equity 37 % +49%
Return On Equity -108 % -63.8%
Return On Assets -78.7 % -49.2%
Operating Margin -3.46K % +89.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 363M shares +116%
Common Stock, Shares, Outstanding 240M shares +43.3%
Entity Public Float 173M USD -15%
Common Stock, Value, Issued 26.8M USD +42.7%
Weighted Average Number of Shares Outstanding, Basic 218M shares +35.5%
Weighted Average Number of Shares Outstanding, Diluted 218M shares +35.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.02M USD +812%
General and Administrative Expense 51.3M USD -7.75%
Operating Income (Loss) -104M USD +1.53%
Nonoperating Income (Expense) -49.8M USD -131%
Income Tax Expense (Benefit) 187K USD -29.4%
Net Income (Loss) Attributable to Parent -154M USD -19.9%
Earnings Per Share, Basic 0 USD/shares -1.25%
Earnings Per Share, Diluted 0 USD/shares -5.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.4M USD +1.47%
Other Assets, Current 1M USD +9.03%
Assets, Current 131M USD +14.5%
Other Long-term Investments 53.9M USD +59.2%
Property, Plant and Equipment, Net 3.01M USD +248%
Operating Lease, Right-of-Use Asset 2.66M USD +158%
Intangible Assets, Net (Excluding Goodwill) 3.03M USD
Goodwill 331K USD
Other Assets, Noncurrent 382K USD -84.3%
Assets 240M USD +21.4%
Accounts Payable, Current 5.37M USD +10%
Accrued Liabilities, Current 10.5M USD -12.5%
Liabilities, Current 16.5M USD -15.8%
Operating Lease, Liability, Noncurrent 2.43M USD +200%
Other Liabilities, Noncurrent 3.19M USD -61.9%
Liabilities 79.9M USD +56.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -21M USD -4.01%
Retained Earnings (Accumulated Deficit) -815M USD -23.3%
Stockholders' Equity Attributable to Parent 160M USD +9.63%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 160M USD +9.29%
Liabilities and Equity 240M USD +21.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.8M USD +21%
Net Cash Provided by (Used in) Financing Activities 59.6M USD
Net Cash Provided by (Used in) Investing Activities -11M USD -196%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 240M shares +43.3%
Common Stock, Par or Stated Value Per Share 0.12 USD/shares +9.09%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 30.8M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 30.4M USD -32.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 590K USD -6.2%
Deferred Tax Assets, Valuation Allowance 140M USD +55.1%
Deferred Tax Assets, Gross 155M USD +28%
Operating Lease, Liability 2.96M USD +178%
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 268K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -155M USD -19.6%
Property, Plant and Equipment, Gross 3.74M USD
Operating Lease, Liability, Current 532K USD +107%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -23.4%
Current Income Tax Expense (Benefit) 100K USD -50%
Unrecognized Tax Benefits 0 USD -100%
Additional Paid in Capital 969M USD +19.9%
Amortization of Intangible Assets 100K USD 0%
Depreciation, Depletion and Amortization 216K USD +160%
Deferred Tax Assets, Net of Valuation Allowance 15.1M USD -50.9%
Interest Expense 2.77M USD +25.5%